Jushu Biotech

Jushu Biotech is a data-driven engineering biology company based in Beijing, China, specializing in the development of synthetic biology technologies, including high-throughput CRISPR genome editing and droplet microfluidic phenotyping for mammalian cells. The organization is actively constructing an engineered cell genotype-phenotype association database, aiming to create next-generation CHO cell lines crucial for advanced biomanufacturing processes, particularly for industrial production in China. Their integrated platform leverages multi-omics data modeling to overcome data silos, thereby enabling more scalable and efficient development of these specialized cell lines. To date, Jushu Biotech has secured over 60 million yuan, equivalent to approximately $9.4 million, through an angel funding round. This capital is designated for critical initiatives such as comprehensive database construction, product development, and the establishment of pilot and mid-scale production lines, alongside process validation. The company was established in 2022.